Scopus Journal Metrics

CiteScore (2018): 2.57

SNIP (2018): 0.997

SJR (2018): 0.583

Platinum Open Access

(no processing or publication fees)

Search

ISSN: 2228-5881 eISSN: 2251-7308

2019, Vol 9, No. 3

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary international open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)
Annual Award

Original Research

1. Synthesis of Novel 1,4- Dihydropyridine Derivatives Bearing Biphenyl-2'-Tetrazole Substitution as Potential Dual Angiotensin II Receptors and Calcium Channel Blockers

Javid Shahbazi Mojarrad, Zahra Zamani, Hossein Nazemiyeh, Saeed Ghasemi, Davoud Asgari*

Adv Pharm Bull. 2011;1(1):1-9. doi: 10.5681/apb.2011.001

PMCID: PMC3849997 PMID: 24312750 Scopus ID: 84875912424

Article

PDF

XML

Cited By:

3

0

Original Research

2. Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action

Hossein Babaei*, Farzaneh Ebrahimi, Javid Shahbazi Mojarrad, Yadollah Azarmi, Afsaneh Gharehbagheri

Adv Pharm Bull. 2011;1(1):10-17. doi: 10.5681/apb.2011.002

PMCID: PMC3849999 PMID: 24312751 Scopus ID: 84875912385

Article

PDF

XML

Cited By:

5

1

Original Research

3. Comparison of Cytotoxic Activity of L778123 as a Farnesyltranferase Inhibitor and Doxorubicin against A549 and HT-29 Cell Lines

Saeed Ghasemi, Soodabeh Davaran, Simin Sharifi, Davoud asgari, Ali Abdollahi, Javid Shahbazi Mojarrad*

Adv Pharm Bull. 2013;3(1):73-77. doi: 10.5681/apb.2013.012

PMCID: PMC3846042 PMID: 24312815 Scopus ID: 84874952509

Article

PDF

XML

Cited By:

5

1

Original Research

4. Synthesis and In Vitro Evaluation of Amphiphilic Peptides and Their Nanostructured Conjugates

Samaneh Mohammadi, Javid Shahbazi Mojarrad, Parvin Zakeri-Milani, Ali Shirani, Samad Mussa Farkhani, Naser Samadi, Hadi Valizadeh*

Adv Pharm Bull. 2015;5(1):41-49. doi: 10.5681/apb.2015.006

PMCID: PMC4352222 PMID: 25789218 Scopus ID: 84924556643

Article

PDF

XML

Cited By:

6

2

Original Research

5. The Relation Between Thermodynamic and Structural Properties and Cellular Uptake of Peptides Containing Tryptophan and Arginine

Ali Shirani, Javid Shahbazi Mojarrad, Samad Mussa Farkhani, Ahmad yari khosroshahi, Parvin Zakeri-Milani, Naser Samadi, Simin Sharifi, Samaneh Mohammadi, Hadi Valizadeh*

Adv Pharm Bull. 2015;5(2):161-168. doi: 10.15171/apb.2015.023

PMCID: PMC4517088 PMID: 26236653 Scopus ID: 84930393567

Article

PDF

XML

Cited By:

4

1

0

Short Communication

6. Vancomycin Capped with Silver Nanoparticles as an Antibacterial Agent against Multi-Drug Resistance Bacteria

Mahsa Esmaeillou, Gholamreza Zarrini*, Mohammad Ahangarzadeh Rezaee, Javid Shahbazi mojarrad, Ali Bahadori

Adv Pharm Bull. 2017;7(3):479-483. doi: 10.15171/apb.2017.058

PMCID: PMC5651071 PMID: 29071232 Scopus ID: 85030115718

Article

PDF

XML

Cited By:

3

0

2

Submit Your Paper Instructions for authors Aims and Scope Editorial Board.Articles ahead of print Indexing Info Editorial policies Ethics & Permissions Archive

Journal Info

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881
Freq.: Quarterly

Quick link

- Editorial Board

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

SCImago Journal & Country Rank